scholarly journals Precise and label-free tumour cell recognition based on a black phosphorus nanoquenching platform

2018 ◽  
Vol 6 (35) ◽  
pp. 5613-5620 ◽  
Author(s):  
Wujuan Yan ◽  
Xiu-Hong Wang ◽  
Jingwen Yu ◽  
Xiaotong Meng ◽  
Pengfei Qiao ◽  
...  

Duplexed recognition of label-free breast cancer cells: a duplexed assay platform based on a BP nanoquencher allows simultaneous detection of two tumor markers within one run.

2020 ◽  
Author(s):  
Santosh Kumar Paidi ◽  
Vaani Shah ◽  
Piyush Raj ◽  
Kristine Glunde ◽  
Rishikesh Pandey ◽  
...  

AbstractIdentification of the metastatic potential represents one of the most important tasks for molecular imaging of cancer. While molecular imaging of metastases has witnessed substantial progress as an area of clinical inquiry, determining precisely what differentiates the metastatic phenotype has proven to be more elusive underscoring the need to marry emerging imaging techniques with tumor biology. In this study, we utilize both the morphological and molecular information provided by 3D optical diffraction tomography and Raman spectroscopy, respectively, to propose a label-free route for optical phenotyping of cancer cells at single-cell resolution. By using an isogenic panel of cell lines derived from MDA-MB-231 breast cancer cells that vary in their metastatic potential, we show that 3D refractive index tomograms can capture subtle morphological differences among the parental, circulating tumor cells, and lung metastatic cells. By leveraging the molecular specificity of Raman spectroscopy, we demonstrate that coarse Raman microscopy is capable of rapidly mapping a sufficient number of cells for training a random forest classifier that can accurately predict the metastatic potential of cells at a single-cell level. We also leverage multivariate curve resolution – alternating least squares decomposition of the spectral dataset to demarcate spectra from cytoplasm and nucleus, and test the feasibility of identifying metastatic phenotypes using the spectra only from the cytoplasmic and nuclear regions. Overall, our study provides a rationale for employing coarse Raman mapping to substantially reduce measurement time thereby enabling the acquisition of reasonably large training datasets that hold the key for label-free single-cell analysis and, consequently, for differentiation of indolent from aggressive phenotypes.


2014 ◽  
Vol 464 (1) ◽  
pp. 99-108 ◽  
Author(s):  
Magdalene Ameka ◽  
Michael P. Kahle ◽  
Mathew Perez-Neut ◽  
Saverio Gentile ◽  
Ahmed A. Mirza ◽  
...  

MEKK2 associates with the scaffold protein paxillin in tumour cell focal adhesions, promoting paxillin ubiquitylation and redistribution to cytoplasm. MEKK2 silencing prolongs paxillin retention in focal adhesions. MEKK2 requires both kinase activity and physical association with paxillin to promote ubiquitylation.


Redox Biology ◽  
2020 ◽  
Vol 36 ◽  
pp. 101617
Author(s):  
Ting Chean Khoo ◽  
Kate Tubbesing ◽  
Alena Rudkouskaya ◽  
Shilpi Rajoria ◽  
Anna Sharikova ◽  
...  

2020 ◽  
Vol 21 (23) ◽  
pp. 9008
Author(s):  
Florian Weinberg ◽  
Diana B. Peckys ◽  
Niels de Jonge

The epidermal growth factor receptor HER2 is overexpressed in 20% of breast cancer cases. HER2 is an orphan receptor that is activated ligand-independently by homodimerization. In addition, HER2 is able to heterodimerize with EGFR, HER3, and HER4. Heterodimerization has been proposed as a mechanism of resistance to therapy for HER2 overexpressing breast cancer. Here, a method is presented for the simultaneous detection of individual EGFR and HER2 receptors in the plasma membrane of breast cancer cells via specific labeling with quantum dot nanoparticles (QDs). Correlative fluorescence microscopy and liquid phase electron microscopy were used to analyze the plasma membrane expression levels of both receptors in individual intact cells. Fluorescent single-cell analysis of SKBR3 breast cancer cells dual-labeled for EGFR and HER2 revealed a heterogeneous expression for receptors within both the cell population as well as within individual cells. Subsequent electron microscopy of individual cells allowed the determination of individual receptors label distributions. QD-labeled EGFR was observed with a surface density of (0.5–5) × 101 QDs/µm2, whereas labeled HER2 expression was higher ranging from (2–10) × 102 QDs/µm2. Although most SKBR3 cells expressed low levels of EGFR, an enrichment was observed at large plasma membrane protrusions, and amongst a newly discovered cellular subpopulation termed EGFR-enriched cells.


2021 ◽  
Vol 35 (S1) ◽  
Author(s):  
Kate Tubbesing ◽  
Ting Khoo ◽  
Pampa Mandal ◽  
Alexander Khmaladze ◽  
Margarida Barroso

2018 ◽  
Vol 19 (10) ◽  
pp. 2920 ◽  
Author(s):  
Hannah Brown ◽  
Gloria Allocca ◽  
Penelope Ottewell ◽  
Ning Wang ◽  
Nicola Brown ◽  
...  

Breast cancer cells colonize the skeleton by homing to specific niches, but the involvement of osteoblasts in tumour cell seeding, colonization, and progression is unknown. We used an in vivo model to determine how increasing the number of cells of the osteoblast lineage with parathyroid hormone (PTH) modified subsequent skeletal colonization by breast cancer cells. BALB/c nude mice were injected for five consecutive days with PBS (control) or PTH and then injected with DiD-labelled breast cancer cells via the intra-cardiac route. Effects of PTH on the bone microenvironment and tumour cell colonization and growth was analyzed using bioluminescence imaging, two-photon microscopy, and histological analysis. PTH treatment caused a significant, transient increase in osteoblast numbers compared to control, whereas bone volume/structure in the tibia was unaffected. There were no differences in the number of tumour cells seeding to the tibias, or in the number of tumours in the hind legs, between the control and PTH group. However, animals pre-treated with PTH had a significantly higher number of tumour colonies distributed throughout skeletal sites outside the hind limbs. This is the first demonstration that PTH-induced stimulation of osteoblastic cells may result in alternative skeletal sites becoming available for breast cancer cell colonization.


Sign in / Sign up

Export Citation Format

Share Document